ANLON HEALTHCARE LIMITED (AHCL): ANLON HEALTHCARE Share Price Rises 9.45% as Market Cap Reaches Rs 826.51 Cr
- September 10, 2026
- Posted by: Harsh Piplani
- Category: News
ANLON HEALTHCARE Share Price was at Rs 17.83, up 9.45% today, with market capitalisation at Rs 826.51 Cr. The move puts ANLON HEALTHCARE LIMITED in focus among healthcare names even though the latest Univest figures confirm the price event without establishing a company-specific catalyst. For investors tracking ANLON HEALTHCARE Share Price Today, the key question is not only why the stock is rising today, but also how the move fits with its valuation, earnings quality and industry positioning. According to latest Univest data, the stock opened at Rs 16.44, touched Rs 18 and saw an intraday low of Rs 16.05. Turnover stood at Rs 3.16 Cr, which helps frame the level of market interest behind the share price rise.
ANLON HEALTHCARE Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 17.83 |
| Previous Close | Rs 16.29 |
| Today's Move | Rs 1.54 (+9.45%) |
| Open | Rs 16.44 |
| High | Rs 18 |
| Low | Rs 16.05 |
| Turnover | Rs 3.16 crore |
| Market Capitalisation | Rs 826.51 crore |
| Market Cap Category | Micro Cap |
ANLON HEALTHCARE LIMITED (AHCL) rose to Rs 17.83 from the previous close of Rs 16.29, a move of Rs 1.54 or 9.45%. The stock opened at Rs 16.44, reached a high of Rs 18, recorded a low of Rs 16.05.
ANLON HEALTHCARE Share Price Today showed a clear upside move as the stock last traded at Rs 17.83 versus the previous close of Rs 16.29, a gain of Rs 1.54 or 9.45%. The price action also showed a range between Rs 16.05 and Rs 18 during the trading session, with the stock opening at Rs 16.44. In practical terms, ANLON HEALTHCARE Stock News today is centred on a strong share price rise rather than any disclosed event trigger. That makes the move relevant for investors who follow ANLON HEALTHCARE Share Price Live and want to understand whether the market is re-rating the stock or simply reacting to short-term buying interest. The latest Univest data also places the company’s turnover at Rs 3.16 Cr, which adds context to the day’s trading activity.
ANLON HEALTHCARE LIMITED (AHCL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 826.51 crore |
| P/E Ratio | 30.37x |
| P/B Ratio | 2.97x |
| ROE | 18.73% |
| ROCE | 21.98% |
| EPS | Rs 0.54 |
| Book Value Per Share | Rs 5.49 |
| Dividend Yield | 0% |
ANLON HEALTHCARE LIMITED (AHCL) fundamental metrics show P/E 30.37x, P/B 2.97x, ROE 18.73%, ROCE 21.98%. These figures provide context only and are not a buy or sell signal.
ANLON HEALTHCARE LIMITED has a market capitalisation of Rs 826.51 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 30.37x, P/B at 2.97x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.73% and ROCE of 21.98%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.54, book value per share of Rs 5.49, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.79x, median ROE of 11.83%, median ROCE of 13.75%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 30.37x |
| Benchmark Median P/E | 32.79x |
| Benchmark Average P/E | 49.1x |
| Benchmark P/E Range | 3.4x to 706.55x |
| Company P/B Ratio | 2.97x |
| Benchmark Median P/B | 3x |
| Company ROE | 18.73% |
| Benchmark Median ROE | 11.83% |
| Company ROCE | 21.98% |
| Benchmark Median ROCE | 13.75% |
| Company Market Capitalisation | Rs 826.51 crore |
| Benchmark Median Market Cap | Rs 759.52 crore |
ANLON HEALTHCARE LIMITED (AHCL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
ANLON HEALTHCARE LIMITED (AHCL) has a P/E ratio of 30.37x, which is below the benchmark median of 32.79x, a difference of -7.38%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
ANLON HEALTHCARE LIMITED (AHCL) has a ROE of 18.73%, which is above the benchmark median of 11.83%, a difference of +58.33%. ANLON HEALTHCARE LIMITED (AHCL) has a ROCE of 21.98%, which is above the benchmark median of 13.75%, a difference of +59.85%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,51,338.9 | 37.06 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,54,068.03 | 86.06 | 14.25 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,88,767.06 | 86.01 | 20.9 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,14,712.94 | 24.95 | 4.18 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,11,803.57 | 32.79 | 3.14 | 11.83 | 16 |
ANLON HEALTHCARE LIMITED (AHCL) has a P/E ratio of 30.37x compared with the displayed peer median of 37.06x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.73% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 21.98% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. ANLON HEALTHCARE LIMITED (AHCL) has a market capitalisation of Rs 826.51 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching ANLON HEALTHCARE
- ANLON HEALTHCARE Share Price rose 9.45% today, keeping the stock in focus among Stocks in News and Top Gainers Today.
- The latest Univest figures show a move from Rs 16.29 to Rs 17.83, with the session range extending from Rs 16.05 to Rs 18.
- ANLON HEALTHCARE Fundamental Analysis shows P/E at 30.37, P/B at 2.97, ROE at 18.73% and ROCE at 21.98%.
- Healthcare sector benchmarking places the stock below the industry median on P/E and near the median on P/B.
- Peer Comparison shows a much smaller market cap than large pharma names, which makes the stock profile distinct within the sector.
About ANLON HEALTHCARE
ANLON HEALTHCARE LIMITED is part of the Pharmaceuticals & Drugs industry within the Healthcare sector. Based on the latest Univest figures, the company is tracked on both NSE and BSE as ANLON HEALTHCARE Share Price interest builds around daily price action and valuation metrics. The business context is important because investors often compare smaller healthcare names with established pharma companies to understand how the market is pricing growth, profitability and capital efficiency.
From a market perspective, the company’s profile is shaped less by size and more by return ratios and earnings multiples. Its market cap of Rs 826.51 Cr, EPS of Rs 0.54 and book value of Rs 5.49 help frame the underlying financial profile, while a zero dividend yield suggests that income is not the current focus of the investment case. For readers following ANLON HEALTHCARE Latest News, the company sits in a segment where sentiment can change quickly, especially when the stock shows a sharp share price rise in a single trading session.
Frequently Asked Questions
Why is ANLON HEALTHCARE Share Price rising today?
Ans. ANLON HEALTHCARE Share Price rose 9.45% to Rs 17.83 today. The latest Univest figures confirm the move, but they do not establish a company-specific catalyst behind the share price rise.
What is ANLON HEALTHCARE Share Price Today?
Ans. ANLON HEALTHCARE Share Price Today is Rs 17.83. It traded above the previous close of Rs 16.29 and moved within an intraday range of Rs 16.05 to Rs 18.
How much did ANLON HEALTHCARE stock gain today?
Ans. ANLON HEALTHCARE stock gained Rs 1.54 today, which equals 9.45%. That made it one of the stronger movers in the Healthcare space during the trading session. The previous close was Rs 16.29.
What is ANLON HEALTHCARE market capitalisation?
Ans. ANLON HEALTHCARE market capitalisation stands at Rs 826.51 Cr. This places the company in the small-cap category and gives context to how the market is valuing the business.
What do ANLON HEALTHCARE valuation ratios show?
Ans. ANLON HEALTHCARE has a P/E of 30.37 and a P/B of 2.97. In the same-industry benchmark, both sit below the median, which keeps valuation close to the middle of the pack.
Are ANLON HEALTHCARE profitability ratios strong?
Ans. ANLON HEALTHCARE reports ROE of 18.73% and ROCE of 21.98%. Both are above the sector benchmark median and average, which adds useful support to the current stock profile.
How does ANLON HEALTHCARE compare with pharma peers?
Ans. ANLON HEALTHCARE is much smaller than Sun Pharma, Divi’s and Torrent, but its P/E, P/B and return ratios compare reasonably with peers such as Zydus and Cipla. Comparable listed companies include Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., Torrent Pharmaceuticals Ltd.
Should investors track ANLON HEALTHCARE Share Price on Univest?
Ans. Yes. Univest lets investors track ANLON HEALTHCARE Share Price, valuation ratios, market cap, sector context and company news together, which helps when the stock is moving sharply in a single session.
Track ANLON HEALTHCARE Share Price on Univest
Use ANLON HEALTHCARE LIMITED (AHCL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track ANLON HEALTHCARE Share Price on Univest for live price updates, market cap, valuation ratios, company financials, sector context and peer comparison. The platform also helps readers follow ANLON HEALTHCARE Share Price Today alongside broader market insights and company news in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
